Monopar Therapeutics, Inc. (MNPR)

NASDAQ: MNPR · IEX Real-Time Price · USD
1.83
-0.03 (-1.35%)
At close: Aug 10, 2022 3:36 PM
1.81
-0.01 (-0.82%)
After-hours: Aug 10, 2022 4:00 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019201820172016
Selling, General & Admin
2.632.442.361.561.170.91
Research & Development
6.494.071.971.770.940.28
Other Operating Expenses
000014.50
Operating Expenses
9.136.514.323.3316.61.19
Operating Income
-9.13-6.51-4.32-3.33-16.6-1.19
Other Expense / Income
-0.02-0.2-0.1-0.1-0.05-0.01
Pretax Income
-9.1-6.3-4.22-3.23-16.55-1.19
Net Income
-9.1-6.3-4.22-3.23-16.55-1.19
Net Income Common
-9.1-6.3-4.22-3.23-16.55-1.19
Shares Outstanding (Basic)
12119999
Shares Outstanding (Diluted)
1211999-
Shares Change
13.82%17.56%0.32%5.80%--
EPS (Basic)
-0.73-0.58-0.45-0.35-1.89-
EPS (Diluted)
-0.73-0.58-0.45-0.35-1.89-
Free Cash Flow Per Share
-0.59-0.42-0.32-0.29-0.30-0.13
EBITDA
-9.1-6.3-4.22-3.23-16.55-1.19
EBIT
-9.1-6.3-4.22-3.23-16.55-1.19
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).